Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
FRG1 maps to a location 100 kb centromeric of the repeat units on chromosome 4q35 which are deleted in facioscapulohumeral muscular dystrophy (FSHD). Zusätzlich bieten wir Ihnen FSHD Region Gene 1 Antikörper (74) und FSHD Region Gene 1 Proteine (6) und viele weitere Produktgruppen zu diesem Protein an.
Our results demonstrate that FRG1 is a direct DUX4 transcriptional target uncovering a novel regulatory circuit contributing to Facioscapulohumeral muscular dystrophy.
FRG1 mice overexpressing FHL1 (zeige FHL1 ELISA Kits) showed an improvement in the dystrophic phenotype
This study suggests a novel role of FRG1 as epigenetic regulator of muscle differentiation and indicates that Suv4-20h1 (zeige SUV420H1 ELISA Kits) has a gene-specific function in myogenesis.
depressed myoblast proliferation may contribute to the pathology of mice overexpressing FRG1 and may play a part in facioscapulohumeral muscular dystrophy
These data provide the first biochemical activities (actin binding and RNA binding) for human FRG1 and the characterization of the endogenous human FRG1, together indicating that FRG1 is involved in multiple aspects of RNA biogenesis.
in muscle FRG1 is a developmentally regulated sarcomeric protein suggesting FRG1 may perform a muscle-specific (zeige EIF3K ELISA Kits) function
FRG1 transgenic mice develop a muscular dystrophy with features characteristic of the human disease; by contrast, FRG2 and ANT1 (zeige SLC25A4 ELISA Kits) transgenic mice seem normal
differently from normal myoblasts, the 4qA/B marker interacted directly with the promoters of the FRG1 and ANT1 (zeige SLC25A4 ELISA Kits) genes in Facio-Scapulo-Humeral Dystrophy cells
Data show that frg1 is expressed in and essential for the development of the tadpole musculature, and suggest that maintenance of normal FRG1 levels is critical for proper muscle development in frogs and humans.
study compared chromatin structure & tridimensional interaction of the D4Z4 array and FRG1 gene promoter, and FRG1 expression, in control and FSHD cells
FRG1 is involved in the morphogenesis of the tooth germ, as well as in the formation of enamel and dentin matrices and that FRG1 may play a role in the odontogenesis in the mouse following BMP4 (zeige BMP4 ELISA Kits) stimulation.
Mouse Frg1 genomic area lacks DUX4 binding sites and DUX4 is unable to activate the endogenous mouse Frg1 gene providing a possible explanation for the lack of muscle phenotype in DUX4 transgenic mice.
On the basis of these results, it was proposed that aberrant fTnT represents a biological marker of muscle phenotype severity and disease progression.
our results suggest that a component of FSHD pathogenesis may arise by over-expression of FRG1, reducing Rbfox1 (zeige A2BP1 ELISA Kits) levels and leading to aberrant expression of an altered Calpain 3 (zeige CAPN3 ELISA Kits) protein through dysregulated splicing
This gene maps to a location 100 kb centromeric of the repeat units on chromosome 4q35 which are deleted in facioscapulohumeral muscular dystrophy (FSHD). It is evolutionarily conserved and has related sequences on multiple human chromosomes but DNA sequence analysis did not reveal any homology to known genes. In vivo studies demonstrate the encoded protein is localized to the nucleolus.
FSHD region gene 1 protein
, facioscapulohumeral muscular dystrophy region gene-1
, protein FRG1
, FSHD region gene 1